E‑News Updates

  • April 16, 2019
    Tags: Big Pharma, CVS, drug cost transparency, drug prices, Express Scripts, Humana, Lloyd Doggett, OptumRx, pharmacy benefit managers, Prime Therapeutics
  • April 9, 2019
    Tags: Abigail Spanberger, Anti-Kickback Statute, brand-name drug, CREATES Act, Devin Nunes, Frank Pallone, free drug samples, Lloyd Doggett, lower drug prices, lower healthcare premiums, Matt Eyles, Seema Verma, SPIKE Act, transition period
  • April 2, 2019
    Tags: Alison Kodjak, Angela Craig, Chuck Grassley, CREATES Act, Frank Pallone, Fred Upton, Greg Walden, Lamar Alexander, lower drug cost, lower healthcare cost, Medicaid, Patty Murray, pay for delay, President Trump, Ron Wyden, Scott Peters, Susan Collins, Xavier Becerra
  • March 26, 2019
    Tags: bundled payments, disclosing prices, drug pricing, drug rebates, Frank Pallone, John O'Brien
  • March 19, 2019
    Tags: Chuck Grassley, Cigna, CVS, Daniel Schumacher, drug pricing, Humana, John Prince, medicare for all, OptumRx, point-of-sale discounts, Pramila Jayapa, Prime Therapeutics, rebate checks, single-payer healthcare, UnitedHealthcare

e-News Archive

Roundtable Activity

  • March 1, 2019
    Tags: drug prices, Lamar Alexander
    The Roundtable has responded to a request from Senator Lamar Alexander (R-TN),Chairman of the Senate Health, Education, Labor, and Pension Committee, seeking specific recommendations to address rising health care costs in the United States. Our response argues the rising cost of health care — especially the rising cost of prescription drugs — severely threatens the […]
  • March 1, 2019
    Tags: drug cost, drug prices, Seema Verma
    In a letter to HHS Secretary Alex Azar and CMS Administrator Seema Verma, the Roundtable described the overwhelming impact the rising cost of prescription drugs is having on Roundtable members and the public sector workers, retirees, and dependents they serve. The letter, which is largely based on data from our annual Pharmacy Survey, offers several policy […]

Activity Archive